Nucleotide sequence analysis of c-raf-1 cDNA and promoter from a radiation-resistant human squamous carcinoma cell line: deletion within exon 17
- PMID: 8352893
- DOI: 10.1002/mc.2940080105
Nucleotide sequence analysis of c-raf-1 cDNA and promoter from a radiation-resistant human squamous carcinoma cell line: deletion within exon 17
Abstract
The c-raf-1 proto-oncogene is the cellular homologue of v-raf, the oncogene of the acutely transforming retrovirus 3611-MSV. The product of c-raf-1 (raf-1) is a 74-kDa cytoplasmic serine/threonine protein kinase. We previously reported that antisense human c-raf-1 cDNA transfection results in reduction of the endogenous c-raf-1 transcript, decreased tumor growth rate, and enhanced radiation sensitivity of SQ-20B tumor cells established from a radiation-resistant laryngeal squamous cell carcinoma. In the study reported here, we used cDNA-linked polymerase chain reaction amplification and nucleotide sequencing to examine the structure of the 3233-bp SQ-20B c-raf-1 cDNA. The 812-bp c-raf-1 promoter region was analyzed by genomic DNA amplification followed by cloning and sequencing. Sequence comparison with a previously published c-raf-1 sequence indicated no structural changes within the coding region of SQ-20B c-raf-1. However, a 4-bp deletion was observed in the 3' untranslated region within exon 17. This deletion was also present in a c-raf-1 cDNA clone isolated from a SQ-20B cDNA library. While the possibility of a 3' transcriptional control mechanism cannot be ruled out, it appears that the raf-1 protein kinase may regulate the development of radioresistant malignancies via interaction with other molecules in the damage and repair-related signal transduction pathways.
Similar articles
-
Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma.Science. 1989 Mar 10;243(4896):1354-6. doi: 10.1126/science.2466340. Science. 1989. PMID: 2466340
-
Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells.Cancer Res. 1992 Nov 15;52(22):6390-3. Cancer Res. 1992. PMID: 1423286
-
Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation.Cancer J Sci Am. 1997 Jan-Feb;3(1):13-20. Cancer J Sci Am. 1997. PMID: 9072302
-
Constitutive modulation of Raf-1 protein kinase is associated with differential gene expression of several known and unknown genes.Mol Med. 1997 Oct;3(10):674-85. Mol Med. 1997. PMID: 9392004 Free PMC article.
-
Complete coding sequence of a human B-raf cDNA and detection of B-raf protein kinase with isozyme specific antibodies.Oncogene. 1990 Dec;5(12):1775-80. Oncogene. 1990. PMID: 2284096 Review.
Cited by
-
Selective Raf inhibition in cancer therapy.Expert Opin Ther Targets. 2007 Dec;11(12):1587-609. doi: 10.1517/14728222.11.12.1587. Expert Opin Ther Targets. 2007. PMID: 18020980 Free PMC article. Review.
-
Biological staging of head and neck cancer and its role in developing effective treatment strategies.Cancer Metastasis Rev. 1996 Mar;15(1):11-25. doi: 10.1007/BF00049485. Cancer Metastasis Rev. 1996. PMID: 8842477 Review.
-
Kinase inhibitors in cancer therapy: a look ahead.Drugs. 2000 Mar;59(3):435-76. doi: 10.2165/00003495-200059030-00004. Drugs. 2000. PMID: 10776829 Review.
-
Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.Cancer Metastasis Rev. 1996 Mar;15(1):27-51. doi: 10.1007/BF00049486. Cancer Metastasis Rev. 1996. PMID: 8842478 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous